Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Expert Rev Proteomics. 2016 Jun;13(6):609–626. doi: 10.1080/14789450.2016.1190651

Table 1.

Advantages and disadvantages of urine specimens for protein biomarker discovery [1,2,28,30,31,44,89,155].

Parameter Advantages Disadvantages
Specimen volume Large quantities available
Ease of collection Non-invasive collection
Urine production Urine is produced continuously throughout the day and can be collected to match normal diurnal variation.
First morning urine samples are generally more concentrated than randomly collected specimens.
Some urinary proteins and chemical constituents are affected by diet, hydration, exercise, metabolism, circadian rhythms and hormones.
Protein quantity Abundant source of soluble proteins/peptides that is less complex than blood.
Protein stability Urine proteins remain relatively stable at room temperature and 4°C for up to 6 hours.
Pathophysiology Urine reflects the plasma proteome as well as kidney proteome due to glomerular filtration, tubular reabsorption, and secretion. A wide spectrum of renal pathologies produces similar urinary proteomic markers, e.g. albuminuria.
Constituents Multiple chemical, cellular, and proteomic constituents are present in urine, many of which are well-defined in normal and pathologic states. Multiple analytes can be selected for data comparison between and within individuals/data sets. Inter and intra-individual variability requires the use of multiple parameters for comparing urinary proteome data. Thoroughly annotated clinical information and/or urine biochemical and microscopic analyses may be needed to accurately compare urine proteomic data.
Analysis Low molecular weight soluble proteins can be readily quantified by mass spectrometry. Urine proteins can be quantified by multiple methods. Urine biochemical analysis can be easily performed with urine test strips (dipstick). Cellular elements can be identified with bright field microscopy.
Strategies for detecting low abundance urinary proteins are well documented and commercially available.
High abundance proteins mask the presence of low abundance proteins, thus requiring depletion and/or enrichment strategies for detecting low abundance proteins.